Research analysts at Craig Hallum initiated coverage on shares of Strata Critical Medical (NASDAQ:SRTA – Get Free Report) in a research note issued to investors on Wednesday, MarketBeat.com reports. The brokerage set a “buy” rating and a $8.00 price target on the stock. Craig Hallum’s price target would indicate a potential upside of 88.24% from the company’s current price.
Separately, B. Riley Financial began coverage on shares of Strata Critical Medical in a report on Wednesday. They set a “buy” rating and a $8.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $8.00.
Check Out Our Latest Stock Report on SRTA
Strata Critical Medical Trading Down 3.0%
About Strata Critical Medical
Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.
Featured Articles
Receive News & Ratings for Strata Critical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Critical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
